NCT03720951

Brief Summary

Prevalence estimates show that prostatitis is one of the most common urological conditions and that symptoms range considerably among men of various socioeconomic status, race, and age. For men under 50 years, prostatitis is the most common urologic outpatient diagnosis. Chronic prostatitis/chronic pelvic pain syndrome has high prevalence estimates internationally ( 16% North America, 14% Asian \& Europeans). Men suffering from Chronic prostatitis/chronic pelvic pain syndrome report significant impairment in their quality of life which is also associated with greater health care expenditures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 26, 2018

Completed
6 days until next milestone

Study Start

First participant enrolled

November 1, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

December 19, 2018

Status Verified

December 1, 2018

Enrollment Period

4 months

First QC Date

October 20, 2018

Last Update Submit

December 16, 2018

Conditions

Keywords

Pulsed Radiofrequencychronic Prostatitis

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Score

    Visual Analogue Score for pain rating( 0 = no pain(minimum) and 10 = the most severe pain(maximum)) will be assessed

    after 1 month of the intervention

Study Arms (2)

Group I(Pudendal n.)

EXPERIMENTAL

Fluoroscopic-guided pulsed R.F. to pudendal nerve bilaterally under image guidance

Radiation: pudendal nerve

Group II(Sacral n.)

EXPERIMENTAL

Fluoroscopic-guided pulsed R.F. to nerve roots S 2, 3, 4 bilaterally under image guidance

Radiation: sacral n roots

Interventions

Fluoroscopic-guided pulsed R.F. to pudendal nerve bilaterally under image guidance

Group I(Pudendal n.)

Fluoroscopic-guided pulsed R.F. to nerve roots S 2, 3, 4 bilaterally under image guidance

Group II(Sacral n.)

Eligibility Criteria

Age20 Years - 75 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA physical status I-III.

You may not qualify if:

  • those with infection at the site of injection,
  • coagulopathy or another bleeding diathesis,
  • a pre-existing neurologic deficit in the targeted region,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut governorate

Asyut, Egypt

RECRUITING

Related Publications (3)

  • Cahana A, Van Zundert J, Macrea L, van Kleef M, Sluijter M. Pulsed radiofrequency: current clinical and biological literature available. Pain Med. 2006 Sep-Oct;7(5):411-23. doi: 10.1111/j.1526-4637.2006.00148.x.

    PMID: 17014600BACKGROUND
  • Issa W, Roumeguere Te, Bossche MV. [Chronic pelvic pain syndrome]. Rev Med Brux. 2013 Jan-Feb;34(1):29-37. French.

    PMID: 23534312BACKGROUND
  • Pontari M, Giusto L. New developments in the diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome. Curr Opin Urol. 2013 Nov;23(6):565-9. doi: 10.1097/MOU.0b013e3283656a55.

    PMID: 24080807BACKGROUND

MeSH Terms

Conditions

Prostatitis

Condition Hierarchy (Ancestors)

Prostatic DiseasesGenital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

ghada Abo Elfadl, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

October 20, 2018

First Posted

October 26, 2018

Study Start

November 1, 2018

Primary Completion

March 1, 2019

Study Completion

April 1, 2019

Last Updated

December 19, 2018

Record last verified: 2018-12

Locations